Outcomes of Allogeneic Stem Cell Transplantation after Inotuzumab Ozogamicin Treatment for Relapsed or Refractory Acute Lymphoblastic Leukemia.
暂无分享,去创建一个
H. Kantarjian | W. Stock | D. DeAngelo | A. Merchant | A. Advani | Hui Zhang | E. Vandendries | N. Gökbuget | R. Cassaday | D. Marks | M. Stelljes | P. Kebriaei | F. Loberiza | Tao Wang | Akil A. Merchant